The Biology: What Happens to Testosterone as You Age
Testosterone doesn't fall off a cliff. It erodes slowly — about 1% per year starting in your mid-30s. By the time most men notice something is off, their levels may have been declining for a decade.
Peak testosterone production typically occurs in late adolescence — around 17 to 19 years old. After 30, levels begin their slow decline. After 35, that decline accelerates slightly and becomes more consistent.
The approximate rate: 1–2% per year in total testosterone. This is an average across large population studies (Harman et al., 2001 Baltimore Longitudinal Study of Aging; Feldman et al., 2002 Massachusetts Male Aging Study).
| Age | Approximate Decline from Peak |
|---|---|
| 30s | 0–10% below peak |
| 40s | 10–20% below peak |
| 50s | 20–35% below peak |
| 60s | 35–50% below peak |
| 70+ | 50%+ below peak |
Importantly, aging also raises SHBG — the protein that binds testosterone and makes it biologically inactive. This means free testosterone (the biologically active fraction) declines faster than total testosterone as you age. A man with total testosterone of 450 ng/dL at 30 had significantly more free testosterone available than a man with the same number at 60.
For the full picture on why free testosterone matters more than total, see Free Testosterone vs. Total Testosterone: Which Number Actually Matters?
"Andropause" vs. "Male Menopause": What's Real, What's Marketing
"Andropause" is modeled loosely on female menopause, but the comparison has important limits:
- Menopause is a discrete biological event — ovarian function ends over 2–5 years, estradiol drops sharply, FSH surges dramatically.
- Age-related testosterone decline is gradual, variable, and most men never reach the functional equivalent of menopause.
The American Urological Association (AUA) and Endocrine Society do not officially recognize "andropause" as a clinical diagnosis. They use the term late-onset hypogonadism (LOH) to describe symptomatic age-related testosterone decline that meets clinical thresholds.
What's real: Testosterone declines with age — consistently confirmed by population studies. Some men's levels fall enough to produce clinical symptoms. Those men can benefit from treatment.
What's marketing: The idea that every man experiences andropause. The implication that testosterone therapy is the solution to normal aging. The use of "andropause" to sell treatment to men with normal-range levels.
The key question is not "do you have andropause" — it's "are your testosterone levels low enough, and your symptoms real enough, to meet the clinical threshold for treatment?"
Normal Aging vs. Clinical Hypogonadism: The Crucial Distinction
| Age-Related Decline (Normal) | Clinical Hypogonadism (Treatable) | |
|---|---|---|
| Definition | Gradual decline within normal range for age | Consistent low T below clinical threshold + symptoms |
| Total T range | 300–700 ng/dL typical in older men | Below 300 ng/dL (two morning samples) per AUA |
| Symptoms | Mild, gradual changes | Significant functional impact |
| LH/FSH | Normal or mildly elevated | Elevated (primary), normal/low (secondary) |
| Treatment indicated | Lifestyle optimization | TRT or SERM therapy may be appropriate |
| Response to lifestyle | Meaningful improvement possible | Variable; often insufficient alone |
The AUA and Endocrine Society define hypogonadism based on: (1) consistently low total T below 300 ng/dL on two morning samples on separate days, (2) specific symptoms consistent with low T — not just "I feel older," and (3) ruling out other causes including sleep apnea, obesity, hypothyroidism, medications, and depression.
The critical variable is where you land on the symptom-lab-context matrix, not your age alone. See Low Testosterone Symptoms in Men and What Causes Low Testosterone? for full context.
What the Decline Feels Like: Symptoms by Domain
| Domain | Symptoms | Typical Onset |
|---|---|---|
| Sexual | Reduced libido, slower arousal, weaker erections, longer recovery | Late 30s–40s |
| Physical | Loss of muscle mass, increased body fat (abdominal), reduced strength | 40s–50s |
| Energy | Fatigue, reduced stamina, poor exercise recovery, afternoon crashes | 40s+ |
| Cognitive | Reduced mental sharpness, word-finding difficulty, lower motivation | 40s–50s |
| Mood | Increased irritability, reduced emotional resilience, mild depression, flat affect | Any age |
| Sleep | Reduced sleep quality, more frequent waking, less restorative sleep | 40s–50s |
| Bone/body composition | Reduced bone density (often silent), increased fracture risk over time | 50s–60s |
The confound problem: Every one of these symptoms can also be caused by poor sleep, metabolic dysfunction, stress, depression, medications, and alcohol use. This is why labs are required to confirm a diagnosis — symptoms alone are not enough.
The Accelerants: What Makes Testosterone Decline Faster Than Average
Age is one input. But several factors dramatically accelerate the decline — and correcting them can meaningfully restore function without any hormonal intervention.
- Obesity / high visceral fat — adipose tissue converts testosterone to estrogen via aromatase; excess body fat also drives insulin resistance, which suppresses LH
- Sleep deprivation — testosterone is primarily produced during sleep (Stage 3); consistently getting 5–6 hours instead of 7–8 measurably suppresses testosterone
- Untreated sleep apnea — suppresses testosterone 20–40% through hypoxia, cortisol elevation, and disrupted LH pulses; many men are undiagnosed. See TRT and Sleep Apnea.
- Chronic stress / elevated cortisol — suppresses GnRH and LH production; cortisol and testosterone are inversely related
- Alcohol — even moderate regular intake reduces testosterone production and raises SHBG
- Sedentary lifestyle — resistance training acutely raises testosterone; inactivity allows steady drift toward lower baseline
- Medications — opioids (direct LH suppression), statins (cholesterol substrate depletion), SSRIs, and several antihypertensives are significant contributors
A man who addresses these variables — loses 20 lbs, gets sleep apnea treated, cuts alcohol, starts lifting — may restore 15–40% of his functional testosterone without any hormonal intervention. Clinical guidelines require ruling out reversible causes before initiating TRT.
The "Normal for Your Age" Problem
When a doctor says "your testosterone is normal for your age," they usually mean your number falls within the reference range for your age bracket. But reference ranges describe the population average — which has been declining. Ranges for 55-year-old men include a lot of men with borderline low function.
What a population reference range cannot answer:
- What was your personal baseline at 25?
- Are your symptoms meaningfully impacting your quality of life?
- Are your free testosterone and SHBG accounted for?
- Are there reversible contributing factors that haven't been addressed?
The practical rule: numbers provide the starting point; symptoms and functional status determine whether treatment is appropriate. Both matter. See Testosterone Levels by Age: Normal Ranges Chart for Men for age-decade reference data.
The Minimum Diagnostic Panel
| Lab | Why It Matters |
|---|---|
| Total testosterone (AM, fasting) | Baseline — must be two morning samples on separate days |
| Free testosterone (calculated, Vermeulen) | SHBG-context read; more reliable than direct assay |
| SHBG | Reveals free T suppression independent of total T level |
| LH + FSH | Distinguishes primary from secondary hypogonadism — determines treatment path |
| Estradiol (sensitive LC/MS assay) | High E2 produces symptoms similar to low T; affects bone and cardiovascular health |
| Hematocrit / CBC | TRT baseline; essential before starting |
| PSA (if 45+) | TRT safety baseline; prostate screening |
| TSH | Thyroid dysfunction mimics low T closely; requires ruling out |
| Prolactin | Elevated prolactin suppresses testosterone; pituitary adenoma must be ruled out if elevated |
| Metabolic panel / HbA1c / insulin | Insulin resistance accelerates T decline and blunts TRT response |
The LH/FSH split is particularly important as men age. Primary hypogonadism (testicular failure — elevated LH) and secondary hypogonadism (suppressed LH from HPG dysfunction) have different treatment implications. Secondary hypogonadism in an older man raises the question of whether a SERM like enclomiphene or clomiphene might restore natural production. See the full TRT Bloodwork Panel guide.
Your Options at Each Stage
Stage 1: T is declining but within range, lifestyle is suboptimal
Target body composition, sleep quality, sleep apnea screening, alcohol reduction, resistance training. Allow 3–6 months of genuine optimization. Expected result: 15–40% functional improvement possible.
Stage 2: T in borderline range (300–400 ng/dL), free T borderline, meaningful symptoms
Lifestyle optimization first. Retest after 3–6 months. If still symptomatic: full panel including LH/FSH. If LH is low/normal: enclomiphene or clomiphene may stimulate natural production. If LH is elevated: testicular failure — TRT is the likely path.
Stage 3: T consistently below 300 ng/dL on two morning samples, significant symptoms
Clinical hypogonadism meets AUA threshold. Full panel required. Rule out contributing factors. TRT is a reasonable and well-evidenced option. See TRT Alternatives: The 7-Tier Decision Framework and TRT Dosage: The Right Starting Dose.
Stage 4: On TRT, optimizing
Retest at 6–8 weeks. Monitor hematocrit, PSA, estradiol, lipids. Adjust protocol based on symptom response and labs. See How Long Does TRT Take to Work?
Does TRT Make Sense for Age-Related Decline?
For men who genuinely meet the clinical threshold — consistently low T plus meaningful symptoms that don't resolve with lifestyle optimization — the evidence is reasonably strong:
- Testosterone Trials (2016, NEJM): largest RCT in older hypogonadal men (790 men, 65+). TRT improved sexual function, libido, bone density, mood, and physical performance compared to placebo.
- TTrials bone sub-study (Snyder 2017, JAMA Internal Medicine): significant bone density improvements — relevant for men 50+ concerned about fracture risk. See Testosterone and Bone Density.
- TRAVERSE Trial (2023): 5,246 men — TRT was non-inferior to placebo for major cardiovascular events. Secondary AFib and PE signals require monitoring. See TRT and Cardiovascular Health: What TRAVERSE Actually Shows.
Where TRT is clearly not indicated for age-related decline: normal T for chronological age with no meaningful symptoms; symptoms driven primarily by lifestyle factors not yet addressed; active or recent prostate cancer; untreated severe sleep apnea (treat apnea first, retest).
What to Do Next
Age-related testosterone decline exists on a spectrum. The question isn't whether your levels are lower than they were at 22 — they almost certainly are. The question is whether they're low enough, and your symptoms real enough, to change the clinical calculus.
A three-step framework:
- Map your symptoms — take the quiz below; it identifies which symptom pattern you're dealing with and whether your presentation looks more like lifestyle-driven decline, borderline hypogonadism, or clinical hypogonadism
- Get the right labs — not just basic testosterone; get SHBG, free T (calculated), LH/FSH, estradiol
- Understand your options — lifestyle optimization, SERMs (enclomiphene, clomiphene), or TRT — each is appropriate at a different point on the spectrum
Not sure where you land? Take the free TRT quiz → — it takes about 4 minutes and maps your symptoms, labs, and history to a clinical picture.